siRNA treatment lowers triglycerides in people with rare problem
.INVESTIGATION EMPHASIZE.19 September 2024.
Plozasiran minimized triglyceride amounts by 80% and lowered the danger of pancreatitis in patients along with relentless chylomicronemia, with or without a genetic prognosis.